Suppr超能文献

影响超声引导微波消融治疗原发性甲状旁腺功能亢进症疗效的因素。

Risk factors influencing cure of ultrasound-guided microwave ablation for primary hyperparathyroidism.

机构信息

Department of Interventional Ultrasound, Chinese PLA General Hospital, Beijing, China.

Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.

出版信息

Int J Hyperthermia. 2022;39(1):258-264. doi: 10.1080/02656736.2022.2029957.

Abstract

OBJECTIVE

To evaluate the potential risk factors influencing cure rate of ultrasound-guided microwave ablation (MWA) for primary hyperparathyroidism (PHPT).

MATERIALS AND METHODS

Seventy five patients (25 males and 50 females; mean age, 56.80 ± 12.34; age range, 26-85) with PHPT undergoing MWA under ultrasound guidance were enrolled between May 2017 and December 2020. The cure rate and complications were evaluated after treatment. The potential factors influencing cure rate of ultrasound-guided MWA for PHPT were analyzed by univariate and multivariate binary logistic regression.

RESULTS

Fifty six of 75 patients had normal PTH and serum calcium levels after at least 6 months after one session MWA, and the cure rate was 74.7% (56/75). 6 uncured patients received the second session MWA during follow-up, and the cure rate achieved 81.3% (61/75) after the second session MWA. Voice changes occurred in 4 patients (5.33%) and recovered within 3 months after ablation without special treatment. Nodule volume was the independent risk factor associated with cure in PHPT patients undergoing MWA, whether after one session ( = 0.0224; odds ratio, 0.67) or the second session MWA ( = 0.0408; odds ratio, 0.74). The cutoff value for nodule volume in predicting the cure was 0.96 cm (one session: sensitivity, 76.8%; specificity, 73.7%; the second session: sensitivity, 72.1%; specificity, 71.4%).

CONCLUSION

In conclusion, parathyroid nodule volume was the independent risk factor associated with cure in PHPT patients undergoing MWA.

摘要

目的

评估影响超声引导微波消融(MWA)治疗原发性甲状旁腺功能亢进症(PHPT)治愈率的潜在危险因素。

材料与方法

2017 年 5 月至 2020 年 12 月,共纳入 75 例接受超声引导下 MWA 治疗的 PHPT 患者(男 25 例,女 50 例;平均年龄 56.80±12.34 岁;年龄范围 26-85 岁)。治疗后评估治愈率和并发症。采用单因素和多因素二项逻辑回归分析影响 PHPT 超声引导 MWA 治愈率的潜在因素。

结果

56 例患者在单次 MWA 后至少 6 个月时甲状旁腺激素和血清钙水平正常,治愈率为 74.7%(56/75)。6 例未治愈患者在随访中接受了第二次 MWA,第二次 MWA 后治愈率达到 81.3%(61/75)。4 例患者(5.33%)出现声音改变,消融后 3 个月内无需特殊治疗即可恢复。结节体积是影响 MWA 治疗 PHPT 患者治愈率的独立危险因素,无论是单次 MWA( = 0.0224;优势比,0.67)还是第二次 MWA( = 0.0408;优势比,0.74)。结节体积预测治愈率的截断值为 0.96 cm(单次 MWA:敏感性 76.8%,特异性 73.7%;第二次 MWA:敏感性 72.1%,特异性 71.4%)。

结论

总之,甲状旁腺结节体积是影响 MWA 治疗 PHPT 患者治愈率的独立危险因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验